Vertex Pharmaceuticals Inc. buy Wolfe Research
Start price
15.02.24
/
50%
€393.55
Target price
15.02.25
€478.13
Performance (%)
15.94%
Price
26.07.24
€456.30
Summary
This prediction is currently active. The prediction currently has a performance of 15.94%. This prediction currently runs until 15.02.25. The prediction end date can be changed by Wolfe_Research at any time. Wolfe_Research has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Vertex Pharmaceuticals Inc. | 0.974% | 0.974% |
iShares Core DAX® | 1.280% | 1.320% |
iShares Nasdaq 100 | -2.457% | -5.192% |
iShares Nikkei 225® | -2.006% | -1.389% |
iShares S&P 500 | -0.662% | -1.884% |
Comments by Wolfe_Research for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $515.00 price target on the stock.
Ratings data for VRTX provided by MarketBeat